Concepedia

Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer

Mitch Dowsett, D A Smithers, John W. Moore, P Trunet, R. Charles Coombes, TJ Powles, R.D. Rubens, I E Smith

European Journal of Cancer · 1994 · 47 citations · 30 references

DOI

Concepts

References

30

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

Richard J. Santen, Steven J. Santner, BONNIE DAVIS et al. · The Journal of Clinical Endocrinology & Metabolism · 1978 · 341 citations

, , +17

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.

Mitch Dowsett, Paul E. Goss, TJ Powles et al. · PubMed · 1987 · 240 citations

, , +17

In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A

Ronald E. Steele, Lynn B. Mellor, Wilbur K. Sawyer et al. · Steroids · 1987 · 217 citations

, , +16

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.

Timothy Iveson, I E Smith, Julie Ahern et al. · PubMed · 1993 · 130 citations

, , +16

Inhibition of Aromatase With CGS 16949A in Postmenopausal Women*

Richard J. Santen, Laurence M. Demers, Herman Adlercreutz et al. · The Journal of Clinical Endocrinology & Metabolism · 1989 · 99 citations

, , +17